Concord Wealth Partners Agios Pharmaceuticals, Inc. Put Options Transaction History
Concord Wealth Partners
- $710 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
247Shares Held
63.1MCall Options Held
682KPut Options Held
890K-
Farallon Capital Management LLC San Francisco, CA5.78MShares$246 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$207 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.71MShares$158 Million3.19% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.76MShares$118 Million1.05% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.33B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...